Arrowhead Pharmaceuticals (ARWR) earnings, Aug 4, 2026: EPS −8%, stock −3.0%
In brief
Arrowhead Pharmaceuticals reported on Aug 4, 2026. Earnings per share changed −8% year over year, 6.5% below the estimate; revenue +171%. The stock opened with a −2.3% gap and closed the day −3.0% (Aug 5, 2026). The stock is now 39.8% below its 52-week high, +42.5% over 12 months. Next report: Nov 12, 2026.
EPS vs estimate−6.5%
EPS, YoY−8%
Revenue, YoY+171%
Gap · day−2.3% · −3.0%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 4, 2026 | −2.3% | −3.0% |
Next-quarter estimates, ratings and the ARWR chart are in the terminal.
Open the terminalFAQ
When is Arrowhead Pharmaceuticals's next earnings report?
Nov 12, 2026. The date comes from daily data and is corrected if the company moves it.
How did Arrowhead Pharmaceuticals stock react to the report?
Opening gap −2.3%, day's result −3.0%.
Did Arrowhead Pharmaceuticals's earnings grow?
Earnings per share fell 8% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.